Showing results (31-40 of 59) with videos related to
Sort By:
Pageof 6
JAMA Neurology|November 3, 2015
Preladenant as an Adjunctive Therapy With Levodopa in Parkinson Disease: Two Randomized Clinical Trials and Lessons LearnedRobert A Hauser, Fabrizio Stocchi, Olivier Rascol, et al.Journal of Clinical Pharmacology|April 24, 2015
Effects of the orexin receptor antagonist suvorexant on respiration during sleep in healthy subjectsNaoto Uemura, Jacqueline McCrea, Hong Sun, et al.Neurology|August 10, 2014
Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine preventionTony W Ho, Kathryn M Connor, Ying Zhang, et al.Headache|November 13, 2010
Long-term tolerability of telcagepant for acute treatment of migraine in a randomized trialKathryn M Connor, Sheena K Aurora, Tom Loeys, et al.The International Journal of Neuropsychopharmacology|June 6, 2017
Phase II Proof-of-Concept Trial of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Major Depressive DisorderKathryn M Connor, Paulette Ceesay, Jill Hutzelmann, et al.Psychopharmacology|June 7, 2011
Additive effects of a cholinesterase inhibitor and a histamine inverse agonist on scopolamine deficits in humansWilliam Cho, Paul Maruff, John Connell, et al.Human Psychopharmacology|March 28, 2013
Randomized controlled study of the T-type calcium channel antagonist MK-8998 for the treatment of acute psychosis in patients with schizophreniaMichael F Egan, Xin Zhao, Andrew Smith, et al.Headache|February 24, 2006
Rofecoxib in the acute treatment of migraine: a randomized controlled clinical trialJoel Saper, Carl Dahlof, Yuen So, et al.Neurology|May 12, 2017
Randomized trial of preladenant, given as monotherapy, in patients with early Parkinson diseaseFabrizio Stocchi, Olivier Rascol, Robert A Hauser, et al.Journal of Sleep Research|August 2, 2021
Pilot evaluation of a consumer wearable device to assess sleep in a clinical polysomnography trial of suvorexant for treating insomnia in patients with Alzheimer's diseaseVladimir Svetnik, Ting-Chuan Wang, Paulette Ceesay, et al.Pageof 6